Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium to its issue price of Rs 570.00. On the National Stock Exchange, the stock was listed at Rs 723.05.

The company, which raised 5.96 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 595.61 lakhs shares.

The company, listed under B Group Securities post its IPO, opened for subscription from Jul 14 to Jul 16.

Following a strong opening, the scrip touched an intraday high of Rs 746.70 and a low of Rs 723.05, before closing the session up by 28.13 per cent to its listing price at Rs 730.35 on the BSE.

The company anticipates using the proceeds of the issue for .

JP Morgan India Private Limited.,JM Financial Institutional Securities Limited.,Citigroup Global Markets India Private Limited,Nomura Financial Advisory & Securities (I) P Ltd. as lead managers & KFin Technologies Ltd. is the registrar, to the issue.

Meanwhile, the broader benchmark BSE Sensex closed trade at 82,200.34, up 442.61 points, or 0.54 per cent.